Pharma Mar, S.A. (PHMMF)
OTCMKTS · Delayed Price · Currency is USD
91.22
0.00 (0.00%)
Aug 10, 2025, 8:00 PM EDT
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of $1.62 billion as of August 12, 2025. Its market cap has increased by 120.30% in one year.
Market Cap
1.62B
Enterprise Value
1.53B
Revenue
222.27M
Ranking
n/a
PE Ratio
32.79
Stock Price
$91.22
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.98B to 1.62B, a decrease of -18.44%. That is a compound annual growth rate of -2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.62B | 12.50% |
| Dec 31, 2024 | 1.44B | 76.17% |
| Dec 29, 2023 | 816.28M | -34.05% |
| Dec 30, 2022 | 1.24B | 5.84% |
| Dec 30, 2021 | 1.17B | -27.21% |
| Dec 31, 2020 | 1.61B | 81.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |